This session will explore the cellular and molecular mechanisms linking obesity to chronic inflammation. Emphasis will be placed on the role of adipose tissue in modulating immune responses and the implications for metabolic health.

This track will examine how immune system dysregulation contributes to the development and progression of obesity. Discussions will include the impact of immune cell populations in adipose tissue and their influence on metabolic disorders.

Focusing on the interplay between adipose tissue and inflammation, this session will address how altered adipose function contributes to metabolic diseases. Research highlighting therapeutic targets within adipose tissue will be presented.

This track will cover the pathophysiological mechanisms underlying obesity-related disorders such as type 2 diabetes and cardiovascular diseases. Innovative management strategies and interventions will also be discussed.

This session will investigate the role of dietary patterns and specific nutrients in modulating obesity and associated inflammatory responses. Evidence-based approaches to nutrition for obesity prevention will be highlighted.

This track will delve into the relationship between chronic inflammation and metabolic health, focusing on how persistent inflammatory states can exacerbate obesity-related conditions. Current research on biomarkers and therapeutic interventions will be featured.

This session will explore novel immunological strategies aimed at preventing obesity and its associated complications. Topics will include vaccine development and immune modulation as potential preventive measures.

This track will examine the role of the gut microbiome in the regulation of obesity and inflammation. Discussions will focus on how microbiome composition influences metabolic health and potential therapeutic applications.

This session will address the unique aspects of obesity in pediatric populations, particularly the inflammatory and immune responses involved. Strategies for early intervention and prevention in children will be a key focus.

This track will highlight translational research efforts aimed at bridging the gap between basic science and clinical applications in obesity and immunology. Innovative studies that translate findings into therapeutic strategies will be presented.

This session will explore emerging trends and future directions in obesity research, including novel therapeutic targets and interdisciplinary approaches. The importance of collaboration across fields to address obesity and its complications will be emphasized.